Vitalone, M J <br/><br/>
Transcriptional profiling of belatacept and calcineurin inhibitor therapy in renal allograft recipients.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Aug 2014 
 - 1912-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.12746  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Adult<br/>Allografts<br/>Biomarkers--metabolism<br/>Biopsy<br/>CTLA-4 Antigen--immunology<br/>Calcineurin Inhibitors--therapeutic use<br/>Cell Differentiation<br/>Cyclosporine--therapeutic use<br/>Female<br/>Fibrosis<br/>Gene Expression Profiling<br/>Gene Expression Regulation<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Transcription, Genetic<br/>Young Adult